bexarotene has been researched along with Cerebral Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, F; Dong, Z; He, B; Xu, F; Xu, L | 1 |
| Amantea, D; Bagetta, G; Certo, M; Endo, Y; Ohta, K; Sakurada, S | 1 |
2 other study(ies) available for bexarotene and Cerebral Ischemia
| Article | Year |
|---|---|
Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats.
Topics: Animals; Apolipoproteins E; Bexarotene; Blood-Brain Barrier; Brain Ischemia; Claudin-5; Disease Models, Animal; Gene Expression Regulation; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Occludin; Rats; Tetrahydronaphthalenes | 2015 |
Activation of RXR/PPARĪ³ underlies neuroprotection by bexarotene in ischemic stroke.
Topics: Animals; Bexarotene; Brain Ischemia; Male; Mice; Mice, Inbred C57BL; Neuroprotection; Neuroprotective Agents; PPAR gamma; Retinoid X Receptors; Stroke; Tetrahydronaphthalenes | 2015 |